Search
for
Sort by
Research 601–630 of 1000+
- Unraveling Ritlecitinib: an in-depth analysis of JAK3 inhibitor for the treatment of alopecia areata
- High-value dermatology: 5 Laboratory tests to reconsider
- Social Pharmacology: Integrating Pharmaceutical and Social Science Research on Drug Effects
- 723 - Efficacy of ritlecitinib in patients with alopecia areata by extent of hair loss at baseline: post hoc analysis of the phase 3 long-term ALLEGRO-LT study
- 44313 Self-Stigmatization and Alopecia Areata; Exploring the Role of Social Support, Helplessness, and Illness Acceptance
- 33774 Baricitinib results in eyebrow and eyelash growth in patients with alopecia areata who do not achieve 20% or less scalp hair loss
- Long COVID: current status in Japan and knowledge about its molecular background
- Hair Mineral Analysis in Children with Atopic Dermatitis
- Script as a Factor in Translation
- Dupilumab's Bidirectional Effects on Alopecia Areata: A Systematic Review
- Dupilumab's Bidirectional Effects on Alopecia Areata: A Systematic Review
- Equity-Oriented Design Processes and Evaluation of Digital Health Technologies for Black Communities Beyond Usability: Scoping Review
- TREATMENT OF KERATOSIS PILARIS: A NARRATIVE LITERATURE REVIEW OF TOPICAL, PROCEDURAL, AND VARIANT-SPECIFIC THERAPIES
- Safety and Efficacy of an Oral Nutraceutical Supplement Gummy and Peptide Serum in Promoting Hair Growth: Initial Results of A Randomized Placebo Controlled Trial with an Open Label Extension
- A Commentary on the Need for Minimum Information for Studies Evaluating Biologics in Plastic Surgery
- Dupilumab for prurigo nodularis: real-world outcomes up to 104 weeks from the Dupilumab Italian Prurigo Nodularis (DUPItaPN) study
- Deucravacitinib, an oral, selective, allosteric tyrosine kinase 2 inhibitor, in patients with alopecia areata: efficacy and safety results of a phase II, multicenter, randomized, double-blinded, placebo-controlled trial
- Methodologic considerations in evaluating early clinical outcomes of GT20029 for androgenetic alopecia
- An occupational perspective of the lived experience of individuals with Alopecia Areata: A scoping review
- 52709 Patient-Reported Outcomes for Scalp, Eyebrow and Eyelash Hair Loss in Patients with Severe Alopecia Areata Treated with Baricitinib: 152 Week Results from two Phase 3 Clinical Trials
- 42063 Image Quality Assessment using Convolutional Neural Network in Clinical Skin Images
- Idiopathic unilateral facial hirsutism
- 25742 Evaluation of the active ingredient complex of an anti-hair loss shampoo on the activation of Wnt/betacatenin pathway in human hair follicle dermal papilla cells
- Kaleidoscope
- 5% Minoxidil topical foam on women: Menopause and other covariates
- Role of Vitamin D Supplementation Therapy on Ovulation and Insulin Resistance in Women with PCOS: A Randomized Controlled Trial
- 570 Examining cutaneous disease activity as an outcome measure for clinical trials in dermatomyositis
- The study of consistent properties of gelatinous shampoo with minoxidil
- Význam vlasů v případě jejich ztráty: Sociologická studie dvou skupin postižených ztrátou vlasů
- Hair and Nail Manifestations of HIV Infection